ChemoCentryx
CCXI
#3210
Rank
NZ$6.36 B
Marketcap
$88.56
Share price
0.00%
Change (1 day)
34.01%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -NZ$0.2 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are NZ$37.2 Million. In 2021 the company made an earning of -NZ$0.22 Billion a decrease over its 2020 earnings that were of -NZ$89.8 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.2 Billion-11.62%
2021 -NZ$0.22 Billion144.84%
2020 -NZ$89.8 Million-1.18%
2019 -NZ$90.87 Million45.17%
2018 -NZ$62.59 Million-305.69%
2017 NZ$30.42 M-144.7%
2016 -NZ$68.08 Million-15.52%
2015 -NZ$80.59 Million0.85%
2014 -NZ$79.91 Million21.47%
2013 -NZ$65.78 Million-1.24%
2012 -NZ$66.61 Million906.88%
2011 -NZ$6.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$2.23 B-1,106.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.03 B-5,510.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.10 B-3,293.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$11.73 Billion 5,167.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.33 B-14,184.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.97 B-3,682.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion 828.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.40 B-733.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$28.09 B-12,726.34%๐Ÿ‡บ๐Ÿ‡ธ USA